MECP2 and attention deficit-hyperactivity disorder: Eventually, MECP2 mutations have been associated with neurodevelopmental disorders such as Angelman-like syndrome and Attention-Deficit Hyperactivity Disorders (ADHD), and occasionally with autism (Ramocki et al., 2009).